PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
Pharmaceutics · 28.01.2024 · 16 (2) · 187
DOI: 10.3390/pharmaceutics16020187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 28.01.2024. Verfasst von Jana Ismail und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstraße 10, 07743 Jena, Germany. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Hybrid nanoparticles (HNPs) were designed by combining a PLGA core with a lipid shell that incorporated PEG–Lipid conjugates with various functionalities (-RGD, -cRGD, -NH2, and -COOH) to create targeted drug delivery systems. Loaded with a neutral lipid orange dye, the HNPs were extensively characterized using various techniques and investigated for their uptake in human monocyte-derived macrophages (MDMs) using FC and CLSM. Moreover, the best-performing HNPs (i.e., HNP-COOH and HNP-RGD as well as HNP-RGD/COOH mixed) were loaded with the anti-inflammatory drug BRP-201 and prepared in two size ranges (dH ~140 nm and dH ~250 nm). The HNPs were examined further for their stability, degradation, MDM uptake, and drug delivery efficiency by studying the inhibition of 5-lipoxygenase (5-LOX) product formation, whereby HNP-COOH and HNP-RGD both exhibited superior uptake, and the HNP-COOH/RGD (2:1) displayed the highest inhibition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstraße 10, 07743 Jena, Germany.
- Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Philosophenweg 14, 07743 Jena, Germany.
- Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Philosophenweg 7, 07743 Jena, Germany.
- Helmholtz Institute for Polymers in Energy Applications Jena (HIPOLE Jena), Lessingstraße 12-14, 07743 Jena, Germany.
- Helmholtz-Zentrum Berlin für Materialien und Energie GmbH (HZB), Hahn-Meitner-Platz 1, 14109 Berlin, Germany.
ORCID-Profile: Jana Ismail, Philipp Dahlke, Antje Vollrath, Paul M Jordan, Ivo Nischang, Stephanie Hoeppener, Oliver Werz
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Ismail, J., Klepsch, L. C., Dahlke, P., Tsarenko, E., Vollrath, A., Pretzel, D., Jordan, P. M., Rezaei, K., Czaplewska, J. A., Stumpf, S., Beringer-Siemers, B., Nischang, I., Hoeppener, S., Werz, O., & Schubert, U. S. (2024). PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs. Pharmaceutics, 16(2), 187. https://doi.org/10.3390/pharmaceutics16020187
Vancouver
Ismail J, Klepsch LC, Dahlke P, Tsarenko E, Vollrath A, Pretzel D, et al. PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs. Pharmaceutics. 2024;16(2):187. doi:10.3390/pharmaceutics16020187
BibTeX
@article{Ismail2024,
author = {Ismail, Jana and Klepsch, Lea C and Dahlke, Philipp and Tsarenko, Ekaterina and Vollrath, Antje and Pretzel, David and Jordan, Paul M and Rezaei, Kourosh and Czaplewska, Justyna A and Stumpf, Steffi and Beringer-Siemers, Baerbel and Nischang, Ivo and Hoeppener, Stephanie and Werz, Oliver and Schubert, Ulrich S},
title = {PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {2},
pages = {187},
doi = {10.3390/pharmaceutics16020187}
}
EUVIMED